Literature DB >> 12888650

Iron-deficient mice fail to develop autoimmune encephalomyelitis.

Sharon M Grant1, Jason A Wiesinger, John L Beard, Margherita T Cantorna.   

Abstract

Determinations of the effects of iron status on the immune system are complicated by the fact that microorganisms and immune cells both utilize iron. To determine the role of iron in immune function, we utilized a model [experimental autoimmune encephalomyelitis (EAE)] in which a strong antigen-specific CD4+ T-cell response develops in the absence of infection. EAE is an autoimmune disease frequently used as a model for the human disease multiple sclerosis (MS). EAE was induced in B10.PL mice fed low iron (1 mg/kg), normal iron (10 mg/kg) or high iron (160 mg/kg) diets that were replete in all other nutrients. Liver iron measurements verified iron status, i.e., low iron mice had 1.9 micro mol/g tissue, normal iron mice, 3.27 micro mol/g tissue and high iron mice, 5.35 micro mol/g tissue. EAE symptoms were most severe in normal iron mice, and EAE did not develop in low iron mice. The incidence of EAE was 71% in normal iron mice, 62% in iron-overloaded mice and 0% in iron-deficient mice. Two of seven mice in the normal iron group developed severe EAE and were euthanized. None of the iron-overloaded mice developed severe EAE. Other measures of EAE severity were similar in the normal and iron-overloaded mice. The data suggest that iron deficiency provides protection from the development of EAE and that iron excess with its potential contribution to free radical formation was not an important factor. The mechanism of EAE inhibition in iron-deficient mice likely involves the delivery and metabolism of iron for optimal CD4+ T-cell development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888650     DOI: 10.1093/jn/133.8.2635

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  24 in total

1.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

3.  Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.

Authors:  S J van Rensburg; M J Kotze; D Hon; P Haug; J Kuyler; M Hendricks; J Botha; F C V Potocnik; T Matsha; R T Erasmus
Journal:  Metab Brain Dis       Date:  2006-05-26       Impact factor: 3.584

4.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

5.  Iron administration reduces airway hyperreactivity and eosinophilia in a mouse model of allergic asthma.

Authors:  H Maazi; S Shirinbak; N Bloksma; M C Nawijn; A J M van Oosterhout
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

Review 6.  Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.

Authors:  Vladimir V Bamm; Arielle M Geist; George Harauz
Journal:  Metab Brain Dis       Date:  2016-11-02       Impact factor: 3.584

7.  Dietary patterns in clinical subtypes of multiple sclerosis: an exploratory study.

Authors:  Geeta S M Ramsaransing; Sanne A Mellema; Jacques De Keyser
Journal:  Nutr J       Date:  2009-08-10       Impact factor: 3.271

8.  Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.

Authors:  Y Ge; J H Jensen; H Lu; J A Helpern; L Miles; M Inglese; J S Babb; J Herbert; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

Review 9.  Iron in multiple sclerosis: roles in neurodegeneration and repair.

Authors:  Erin Stephenson; Nabeela Nathoo; Yasamin Mahjoub; Jeff F Dunn; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

10.  Deep gray matter T2 hypointensity correlates with disability in a murine model of MS.

Authors:  Istvan Pirko; Aaron J Johnson; Anne K Lohrey; Yi Chen; Jun Ying
Journal:  J Neurol Sci       Date:  2009-01-21       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.